Dr Kirsty Bannister PhD
- Principal Investigator
I lead the Bannister lab group, where we focus on the biological, pharmacological and anatomical basis of pain pathways and their plasticity in chronic pain states. Chronic pain affects up to 20% of the adult population and can occur in the presence or absence of any past injury or evidence of body damage. Modules that I teach on include Physiology and Pharmacology of the Central Nervous System, Pharmacology of Neurological and Psychiatric Disorders, Core Year One Fundamentals of Pharmacology, and Neuroscience. My lab's research is funded by the Academy of Medical Sciences and the NC3Rs.
Please see my Research Staff Profile for more detail
- Kucharczyk et al., 2020. The impact of bone cancer on the peripheral encoding of mechanical pressure stimuli. Pain.
- Cummins et al., 2020. Activation of the descending pain modulatory system using cuff pressure algometry: Back translation from man to rat. European Journal of Pain.
- Bannister et al., 2019. Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain. Pain
- Bannister et al., 2017. Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain. Pain
- Bannister et al., 2015. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations. Pain
- Professor Thomas Graven-Nielsen, Aalborg University, Denmark
- Professor Irene Tracey, Oxford University, UK
- Professor Frank Porreca, University of Tucson, USA
- Professor Anthony Dickenson, University College London, UK